Company intelligence / Profile preview

Trendlines Group

Misgav, Northern District, Israel

Ownership: Private
Employees: ~30
Development stage: Other

Overview

The Trendlines Group is a major Israeli-Singaporean investment and commercialization company operating as an incubator for medtech, agrifood, and related health/life science innovations. Numerous devices and technologies originating from its portfolio are FDA-cleared, in clinical/market entry, or in late-stage development. Successful exits (ApiFix, OrthoSpin), numerous strategic and licensing partnerships, and a global investment/innovation network support a robust pipeline of early-to-commercial stage products.

Therapeutic areas: UrologyCardiovascularWomen's HealthGastroenterologyOtherDermatologyOncology
Modalities: DeviceSmall moleculeBiologicAntibodyAntibody-drug conjugateCell therapyPeptidesRNA therapy
Industry: Investors

Partnerships

Röchling MedicalBayer Crop Science

Beyond the preview

Go deeper on Trendlines Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trendlines Group.

Explore the full profile